- Home
- MRK vs TMO Comparison
MRK vs TMO Comparison
Compare MRK & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- TMO
- Stock Information
- Founded
- MRK 2000
- TMO 1956
- Country
- MRK United States
- TMO United States
- Employees
- MRK N/A
- TMO N/A
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- TMO Industrial Machinery/Components
- Sector
- MRK Health Care
- TMO Industrials
- Exchange
- MRK Nasdaq
- TMO Nasdaq
- Market Cap
- MRK 260.8B
- TMO 211.0B
- IPO Year
- MRK N/A
- TMO N/A
- Fundamental
- Price
- MRK $98.13
- TMO $523.89
- Analyst Decision
- MRK Buy
- TMO Strong Buy
- Analyst Count
- MRK 15
- TMO 18
- Target Price
- MRK $129.07
- TMO $650.72
- AVG Volume (30 Days)
- MRK 14.0M
- TMO 2.3M
- Earning Date
- MRK 02-04-2025
- TMO 01-29-2025
- Dividend Yield
- MRK 3.30%
- TMO 0.30%
- EPS Growth
- MRK 165.47
- TMO 4.56
- EPS
- MRK 4.78
- TMO 15.95
- Revenue
- MRK $63,174,000,000.00
- TMO $42,370,000,000.00
- Revenue This Year
- MRK $7.49
- TMO $0.85
- Revenue Next Year
- MRK $4.97
- TMO $5.15
- P/E Ratio
- MRK $20.51
- TMO $32.85
- Revenue Growth
- MRK 6.51
- TMO N/A
- 52 Week Low
- MRK $94.48
- TMO $493.30
- 52 Week High
- MRK $134.63
- TMO $627.88
- Technical
- Relative Strength Index (RSI)
- MRK 40.69
- TMO 44.94
- Support Level
- MRK $97.82
- TMO $508.86
- Resistance Level
- MRK $101.50
- TMO $535.94
- Average True Range (ATR)
- MRK 2.19
- TMO 10.26
- MACD
- MRK -0.19
- TMO 0.76
- Stochastic Oscillator
- MRK 4.28
- TMO 44.81
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of mid-2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (22%); and lab products and services, which includes CRO services (54%).